Shankar G. Alegaon
Shankar G. Alegaon publishes mostly in Organic Chemistry, Molecular Biology and Computational Theory and Mathematics, on topics such as Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds and Click Chemistry and Applications.
- World rank
- #686,865 of 7,710,434 ranked researchers
- Rank in India
- #8,745 of 280,097
- Works
- 60
- Citations
- 1.2k
- Citations per work
- 19.4
What does Shankar G. Alegaon research?
Shankar G. Alegaon's work is mostly in Chemistry (60%), Biochemistry, Genetics and Molecular Biology (19%), Computer Science (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences3965.5%
- Chemistry3660.2%
- Computer Science35.3%
- Life Sciences1118.7%
- Everything else711.7%
- Health Sciences24.1%
- Medicine24.1%
- 1Organic Chemistry60% of their works
- 2Molecular Biology16% of their works
- 3Computational Theory and Mathematics5% of their works
- 4Cell Biology3% of their works
- 5Endocrinology, Diabetes and Metabolism2% of their works
- 6Physiology2% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- Computational Drug Discovery Methods
- Multicomponent Synthesis of Heterocycles
- Quinazolinone synthesis and applications
- Synthesis and Biological Evaluation
- Synthesis of heterocyclic compounds
Which keywords describe Shankar G. Alegaon's research?
The keywords of their largest research topics: Medicinal Chemistry, Anticancer Agents, Heterocyclic Compounds, Tubulin Inhibitors, Vascular Targeting Agents, Synthesis, Drug Discovery and Biological Evaluation.
- Quinoxaline
- Antimicrobial Activity
- Quinazoline
- Indirubin
- Virtual Screening
- Copper-Catalyzed Cycloaddition
- Triazines
- Heterocycles
- Anticancer
- Biological Evaluation
- Synthesis
- Tubulin Inhibitors
- Anticancer Agents
- Medicinal Chemistry
- Heterocyclic Compounds
- Vascular Targeting Agents
- Drug Discovery
- Molecular Docking
- Antimicrobial
- Scaffold
- Click Chemistry
- Drug Target Identification
- Green Chemistry
- Multicomponent Reactions
- Annulation
- Ketene Dithioacetal
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Medicinal Chemistry563 topics
- Anticancer Agents472 topics
- Heterocyclic Compounds472 topics
- Tubulin Inhibitors401 topic
- Vascular Targeting Agents401 topic
- Synthesis344 topics
- Drug Discovery303 topics
- Biological Evaluation273 topics
- Molecular Docking212 topics
- Anticancer202 topics
- Antimicrobial202 topics
- Heterocycles192 topics
- Scaffold121 topic
- Triazines121 topic
- Click Chemistry101 topic
- Copper-Catalyzed Cycloaddition101 topic
- Drug Target Identification91 topic
- Virtual Screening91 topic
- Green Chemistry81 topic
- Indirubin81 topic
- Multicomponent Reactions81 topic
- Quinazoline81 topic
- Annulation71 topic
- Antimicrobial Activity71 topic
- Ketene Dithioacetal71 topic
- Quinoxaline71 topic
Where does Shankar G. Alegaon work?
Shankar G. Alegaon's main affiliation in the publication record is KLE University, India.
How many publications and citations does Shankar G. Alegaon have?
OpenAlex counts 60 works and 1,166 citations for Shankar G. Alegaon, an h-index of 21, ranking #686,865 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shankar G. Alegaon. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.